The group’s principle activity is to develop innovative therapies in women's health. The group has developed a non-surgical approach to treat stress urinary incontinence due to bladder outlet hypermobility. The group operates from United States.
Executive Information
Name
Title
Email
Debra Reisenthel
Dir., CEO, Pres.
N/A
Charles Carignan
Chief Medical Officer, VP - Business Development, Clinical, Regulatory Affairs
